The COST Action INFLAMomx – Pan-European Network for Inflammaging: A Multi-omics Integration Approach – has launched.
INFLAMomx aims to consolidate resources on non-communicable diseases (NCDs) and to study them through the lens of inflammaging – the chronic, low-grade inflammation associated with ageing – using cutting-edge multi-omics approaches.
The Action brings together 75 researchers from 24 European countries and is coordinated by a multidisciplinary consortium spanning molecular biology, bioinformatics, and clinical medicine. By leading WG3, EATRIS plays a key role in supporting the translation of multi-omics findings into clinical practice.
The project’s overarching goal is to strengthen Europe’s capacity in computational biology and inflammaging research by developing a harmonised, open, and standardised framework for multi-omics data integration. By doing so, INFLAMomx will provide insight into the biological mechanisms underlying age-related diseases, inform prevention strategies, and support the transition from disease-centric to health-centric healthcare models.
The Action will also establish an online repository of inflammaging-related multi-omics studies and biomarkers, and create best-practice guidelines for data integration, reproducibility, and clinical translation. A strong training component will develop the next generation of scientists with integrative skills, bridging wet-lab and computational expertise.
EATRIS contributes to the project by linking existing omics and biobanking infrastructures and facilitating access to expertise and technology platforms across Europe. Through its engagement, EATRIS helps ensure that the outputs of INFLAMomx can be effectively used to advance translational and preventive medicine.
The network also prioritises inclusiveness and capacity building. Researchers from less research-intensive countries will be given access to training schools, short-term scientific missions, and mentoring schemes to foster wider participation in systems biology and personalised medicine.
Ultimately, INFLAMomx will help pioneer preventive strategies that target inflammaging as a shared mechanism behind many NCDs, improving quality of life and reducing the burden on Europe’s healthcare systems.
More information about participation opportunities will be available on the COST website.
- See the project website here.
- Find out more about COST Action here.
